在前列腺癌患者中,与第二代雄激素受体对抗剂相关的严重皮肤不良反应
Junfa Liu1, Xiongfei Liu2, Hongbo Zeng1
1Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
PloS one
|June 10, 2025
概括
用于前列腺癌的第二代雄激素受体抗剂 (SGARAs),如阿帕胺,可能会增加严重皮肤不良反应 (SCARs) 的风险. 患者需要密切监测,特别是阿帕胺,用于早期发现和管理SCAR.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药物监督 药物监督 药物监督
背景情况:
- 前列腺癌是男性的主要癌症,通常用抗雄激素剥夺疗法 (ADT) 治疗.
- 第二代雄激素受体抗剂 (SGARAs),如恩扎胺,阿帕胺和达罗胺是ADT的关键药物.
- 严重的皮肤不良反应 (SCAR) 是药物相关的罕见但可能致命的副作用.
研究的目的:
- 通过药监数据调查SGARAs和SCARs之间的潜在关联.
- 为了比较恩扎胺,阿帕胺和达罗胺中SCARs的风险信号.
主要方法:
- 使用了四种不成比例分析算法:ROR,PRR,BCPNN和MGPS.
- 分析了与SGARA相关的SCARs报告的病例,直到2024年第二季度.
- 检查了报告的SCAR病例的发病时间和人口统计数据.
主要成果:
- 在所有四种分析方法中,阿帕胺对SCARs显示了积极的信号.
- 在本分析中,恩扎胺和达罗胺没有为SCARs产生积极信号.
- 与恩扎胺和达罗胺相比,阿帕胺更频繁地报告了SCAR,其中恩扎胺的发病时间高达176天,阿帕胺的发病时间高达126天.
结论:
- SGARA,特别是阿帕胺,在前列腺癌患者中构成SCAR的潜在风险.
- 与恩扎胺和达罗胺相比,阿帕胺似乎有较高的SCAR报告频率.
- 加强和长时间的患者监测对于早期检测和管理SCARs至关重要,当使用SGARAs,特别是 apalutamide.
相关概念视频
01:20Disorders of the Male Reproductive System
354
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
354
01:22Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
559
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
559
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
159
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
159
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
139
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
139
01:30Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
600
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
600